Phospho-PAK7/PAK6 (Ser602/Ser560) Antibody

What Are PAK7 and PAK6 Proteins and What Critical Functions Do They Perform in Cell Signaling?

PAK7 (also known as PAK5) and PAK6 are members of the p21-activated kinase (PAK) family of serine/threonine kinases. These proteins function as Rac/Cdc42-associated Ste20-like kinases characterized by:

• A highly conserved amino-terminal Cdc42/Rac interactive binding (CRIB) domain

• A carboxyl-terminal kinase domain that phosphorylates downstream targets

PAK7/PAK6 regulate multiple essential cellular processes including:

• Cytoskeletal reorganization and cell motility

• Cell survival through anti-apoptotic functions

• Cell proliferation and cell cycle progression

• Cell-cell adhesion dynamics

• Signal transduction in multiple pathways

Notably, PAK6 targets to cell-cell adhesions through its N-terminus , while PAK7 shuttles between mitochondria and nucleus, protecting cells from apoptosis by phosphorylating Bcl2-associated agonist of cell death in mitochondria . These kinases have emerged as important regulators in both normal physiology and pathological conditions, particularly in cancer progression and neurodegeneration.

What Is the Significance of the Ser602/Ser560 Phosphorylation Sites in Experimental Design?

The Ser602 (PAK7) and Ser560 (PAK6) residues represent critical autophosphorylation sites that indicate the activation status of these kinases. These phosphorylation events carry several important experimental implications:

• They serve as reliable biomarkers for PAK7/PAK6 activation in cell-based systems

• Phosphorylation at these sites directly corresponds to increased kinase activity

• These modifications mediate downstream effects on multiple cellular processes

In neuronal cells, mTORC1 inhibition significantly enhances PAK6 activity as measured by increased phosphorylation at Ser560 . Western blot analysis using phospho-specific antibodies against these sites allows researchers to monitor kinase activation in response to cellular stimuli, pathway inhibitors, or genetic manipulations. This phosphorylation status provides a direct readout of PAK7/PAK6 functional state, making these sites particularly valuable for experimental assessment.

How Can Researchers Validate the Specificity of Phospho-PAK7/PAK6 (Ser602/Ser560) Antibody?

Verifying antibody specificity is crucial for obtaining reliable experimental results. For Phospho-PAK7/PAK6 (Ser602/Ser560) antibodies, several complementary validation approaches are recommended:

Peptide Competition Assay

• Treat one sample with antigen-specific peptide before antibody incubation

• Specific signal should disappear in peptide-treated samples

• Western blot analysis of HeLa cell extracts has demonstrated this approach

Genetic Validation

• Compare antibody signal between wild-type and PAK7/PAK6 knockdown cells

• Specific signal should proportionally decrease in knockdown cells

• Lentiviral shRNA delivery has achieved ~90% reduction in PAK6 protein expression

Phosphatase Treatment Controls

• Treat lysates with lambda phosphatase to remove phosphate groups

• Phospho-specific signal should be eliminated while total protein remains detectable

Stimulation/Inhibition Experiments

• Compare basal versus stimulated conditions known to affect phosphorylation

• For example, treating cells with mTORC1 inhibitor Torin1 increases PAK6 phosphorylation at Ser560

It's important to note that "The phospho-antibody used is not specific for PAK6, as this phospho-site is conserved in PAK4, PAK5 and PAK6; nevertheless, the use of cells overexpressing PAK6 and the significant difference in the antibody signal between the two lines indicate that the observed effects are PAK6-dependent" . This consideration is particularly important when designing experiments with cell lines expressing multiple PAK family members.

PAK7/PAK6 have emerged as important regulators of cancer biology with significant implications for therapeutic resistance:

Hepatocellular Carcinoma (HCC)

• PAK7 is significantly upregulated in poorly differentiated HCC cells

• Knockdown of PAK7 enhances radiosensitivity of HCC cells through multiple mechanisms:

  • Reduced cell viability after irradiation

  • Decreased clone formation ability

  • Increased apoptotic rate (from 8.04% to 28.53% in Mahlavu cells and from 15.95% to 35.4% in Huh7 cells after irradiation)

• PAK7 may confer radioresistance through enhanced DNA repair activity

Breast Cancer

• PAK7 phosphorylates GATA1 to recruit HDA3/4 to E-cadherin promoter, suppressing E-cadherin expression

• This suppression promotes epithelial-mesenchymal transition in breast cancer cells

• PAK7 enhances NF-κB signaling by promoting phosphorylation and nuclear translocation of p65 subunit

• PAK5-Egr1-MMP2 signaling pathway regulates cell migration and invasion

Cellular Mechanism Analysis

Studies reveal that PAK7 functions as a "cancer addictive oncogene" with expression levels correlating directly with radiation resistance. High PAK7 expression cells (Mahlavu and SK-Hep-1) show minimal killing effect after irradiation, while PAK7-low HepG2 cells and PAK7-moderate Huh7 cells demonstrate significant response . These findings suggest PAK7/PAK6 as promising therapeutic targets to overcome radioresistance in cancer treatment.

How Does PAK7/PAK6 Phosphorylation Status Change in Response to mTORC1 Inhibition?

The relationship between mTORC1 signaling and PAK7/PAK6 activation reveals important regulatory mechanisms with implications for cellular homeostasis:

Direct Impact on Phosphorylation

• mTORC1 inhibition by Torin1 significantly enhances PAK6 phosphorylation at Ser560

• This effect is observed in both native and PAK6-overexpressing neuroblastoma cells

• The effect can be visualized through both confocal imaging and immunoblot analysis

Mechanistic Connection to Autophagy

• PAK6 functions downstream of mTORC1 in regulating autophagy

• While PAK6 knockout/knockdown doesn't completely block autophagy, it reduces its magnitude

• This suggests PAK6 acts as a fine-tuner rather than an essential component of autophagic processes

Neuroprotective Implications

PAK6's involvement in this pathway has significant therapeutic potential: "PAK6 acts in the major pathway of TFEB regulation, i.e. downstream of mTORC1... increasing PAK6 activity in the brain, e.g. through blood brain barrier penetrant compounds or via gene therapy, may be explored as a future therapeutic strategy for PD and other neurodegenerative disorders where autophagy activation is considered beneficial."

This connection positions PAK6 as an important integrator of nutrient sensing and cellular quality control mechanisms, particularly in neuronal contexts.

How Do PAK7/PAK6 Interact with Other Major Signaling Pathways?

PAK7/PAK6 function as important nodes in complex signaling networks, interacting with several major pathways:

Wnt/β-catenin Pathway

• PAK7 directly interacts with and activates Wnt/β-catenin signaling

• PAK7 and β-catenin co-localize in the nucleus, suggesting potential transcriptional cooperation

• This interaction has implications for developmental processes and cancer progression

NF-κB Signaling Axis

• PAK7 promotes phosphorylation and nuclear translocation of p65 subunit of NF-κB

• This activation enhances proliferation by increasing cyclin D1 expression

• The PAK7-NF-κB-cyclin D1 axis represents a significant oncogenic mechanism

Transcriptional Regulation

• PAK7 phosphorylates GATA1, recruiting HDA3/4 to the E-cadherin promoter

• This epigenetic modification suppresses E-cadherin expression

• Loss of E-cadherin promotes epithelial-mesenchymal transition in cancer cells

Androgen Receptor Signaling

• PAK6 interacts with androgen receptor (AR)

• This interaction affects steroid hormone-dependent transcription

• AR signaling is crucial for male sexual differentiation and development

Autophagy-Lysosomal Pathway

• PAK6 regulates TFEB nuclear translocation

• TFEB is a master transcriptional regulator of lysosomal biogenesis and autophagy

• This connection positions PAK6 as a modulator of cellular quality control systems

These diverse interactions highlight PAK7/PAK6 as integrators of multiple cellular signaling networks, affecting outcomes from development to disease.

What Cellular Processes Are Regulated by PAK7/PAK6 Phosphorylation?

PAK7/PAK6 phosphorylation regulates numerous cellular processes through various downstream targets:

Apoptosis Regulation

• PAK7 shuttles between mitochondria and nucleus

• It phosphorylates Bcl2-associated agonist of cell death in mitochondria

• This phosphorylation confers resistance to apoptosis

• PAK7 deletion increases apoptosis in breast cancer and osteosarcoma cells

Cell Proliferation and Survival

• PAK7/PAK6 activation promotes cell proliferation in various cancer types

• Knockout of PAK7 inhibits proliferation and colony formation of human osteosarcoma cells

• Transfection of PAK7 shRNAs enhances radiation-induced decrease in HCC cell viability

Cell Migration and Invasion

• PAK5-Egr1-MMP2 signaling regulates cell migration and invasion in breast cancer

• PAK kinases mediate cytoskeletal rearrangement affecting cell motility

• These functions contribute to metastatic potential

Cell-Cell Adhesion

• PAK6 targets to cell-cell adhesions through its N-terminus

• This localization occurs in a Cdc42-independent manner

• PAK6 may regulate adhesion dynamics and epithelial integrity

Autophagy Regulation

• PAK6 promotes neuronal autophagy by regulating TFEB nuclear translocation

• It acts as a fine-tuner of the autophagy-lysosomal pathway

• This function has implications for neurodegenerative diseases

DNA Damage Response

• High PAK7 expression enhances DNA repair activity

• This contributes to radioresistance in cancer cells

• Targeting PAK7 could potentially sensitize tumors to radiation therapy

These diverse functions position PAK7/PAK6 as central regulators in both normal cellular physiology and disease states, making them important subjects for continued research.

What Experimental Models Are Most Suitable for Studying PAK7/PAK6 Function?

Selecting appropriate experimental models is crucial for investigating PAK7/PAK6 biology. The following models have proven valuable:

Cell Culture Systems

Genetic Manipulation Approaches

• shRNA knockdown systems for specific targeting of PAK7/PAK6

• Stable overexpression models for gain-of-function studies

• CRISPR/Cas9 knockout for complete elimination of PAK expression

Animal Models

• PAK6 knockout mice are viable, suggesting compensatory mechanisms

• Drosophila models for studying PAK6 effects on α-synuclein accumulation

• Mouse models of LRRK2-PD for studying PAK6 in dopaminergic neurons

Functional Assays

• SRB assay for cytotoxicity and radiation sensitivity assessment

• Clonogenic assays for cell survival and proliferation

• Flow cytometry for quantifying apoptosis

• Western blotting for detecting phosphorylated PAK7/PAK6

• Confocal imaging for assessing subcellular localization

Pathway Manipulation

• mTORC1 inhibition with Torin1 to study PAK6 activation

• Irradiation (IR) to investigate PAK7's role in radioresistance

• Phosphatase treatment to assess phosphorylation dynamics

This multi-faceted approach allows researchers to comprehensively investigate PAK7/PAK6 function across different biological contexts and disease states.

How Can Researchers Distinguish Between PAK4, PAK5(PAK7), and PAK6 in Experimental Systems?

Distinguishing between these closely related kinase family members presents a significant challenge in experimental settings:

Antibody Selection Strategies

• Use isoform-specific antibodies targeting unique epitopes outside conserved regions

• Validate antibody specificity using overexpression and knockdown controls

• Note that phospho-sites like Ser602/Ser560 are conserved across PAK4, PAK5(PAK7), and PAK6

Genetic Approaches

• Employ selective knockdown/knockout of specific PAK isoforms

• Perform rescue experiments with isoform-specific constructs

• Create cell lines with tagged versions of individual PAK proteins

Expression Pattern Analysis

• Leverage tissue-specific expression patterns (PAK6 is enriched in brain and testis)

• Utilize cell lines with predominant expression of specific PAK isoforms

• Perform qPCR to quantify relative expression levels of each isoform

Functional Differentiation

• PAK6 uniquely localizes to cell-cell adhesions through its N-terminus

• PAK7/PAK5 demonstrates distinct nuclear-mitochondrial shuttling

• PAK isoforms show differential responses to upstream regulators

When using phospho-specific antibodies that recognize conserved sites, researchers should incorporate additional controls: "The phospho-antibody used is not specific for PAK6, as this phospho-site is conserved in PAK4, PAK5 and PAK6; nevertheless, the use of cells overexpressing PAK6 and the significant difference in the antibody signal between the two lines indicate that the observed effects are PAK6-dependent" .